Impairment of colorectal cancer screening during the COVID-19 pandemic
- PMID: 34015352
- PMCID: PMC9259279
- DOI: 10.1016/S2468-1253(21)00098-4
Impairment of colorectal cancer screening during the COVID-19 pandemic
Conflict of interest statement
We declare no competing interests. LR is in receipt of investigator grant 21723 and LL of investigator grant 22234 from the Italian Foundation for Cancer Research.
Comment in
-
Impairment of colorectal cancer screening during the COVID-19 pandemic.Lancet Gastroenterol Hepatol. 2021 Jun;6(6):426. doi: 10.1016/S2468-1253(21)00136-9. Lancet Gastroenterol Hepatol. 2021. PMID: 34015353 Free PMC article. No abstract available.
Comment on
-
Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study.Lancet Gastroenterol Hepatol. 2021 Apr;6(4):304-314. doi: 10.1016/S2468-1253(21)00003-0. Epub 2021 Feb 3. Lancet Gastroenterol Hepatol. 2021. PMID: 33548185 Free PMC article.
References
-
- de Jonge L, Worthington J, van Wifferen F, et al. on behalf of the COVID-19 and Cancer Global Modelling Consortium working group 2 Impact of the COVID-19 pandemic on faecal immunochemical test-based colorectal cancer screening programmes in Australia, Canada, and the Netherlands: a comparative modelling study. Lancet Gastroenterol Hepatol. 2021;6:304–314. - PMC - PubMed
-
- Rapporto sui ritardi accumulati dai programmi di screening Italiani in seguito alla pandemia da Covid-19 Secondo rapporto al 30 Settembre. 2020. https://www.osservatorionazionalescreening.it/sites/default/files/allega...
-
- Buscarini E, Benedetti A, Monica F, et al. on behalf of the Italian Federation of Digestive Diseases Societies. Changes in digestive cancer diagnosis during the SARS-CoV-2 pandemic in Italy: a nationwide survey. Dig Liver Dis (in press). - PubMed
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
